New embarrassingly bad study of ivermectin is a textbook example of “confounding by indication”
In short a retroactive database review found that people w/ COVID did worse if given remdesivir (only given to sick inpatients) than ivermectin (only given to well outpatients)🤔 1/
There are many problems with this “study”.
First it’s generous to even call it a “study.” It’s an *abstract* of a retrospective database review. The whole “article” is less than a page (see below).
They found 1.7 million people w/ COVID. Out of this group they identified 1,072 who received ivermectin (not exactly widely used) & 40k who received remdesivir
The groups were very dissimilar: IVM was 10 yrs younger. They don’t report any comorbidities 3/
Despite the groups being wildly dissimilar, they *somehow* adjusted for potential compounders. (They don’t say how)
Crucially they did NOT adjust for hospitalization status. This means they compared COVID outpatients (on IVM) to COVID inpatients (on remdesivir). 🍎to🍊
4/
The authors are interesting…
The first two are medical students, the 3rd is a plastic surgery resident.
(Nothing wrong with this, though it is weird for the MS not to be affiliated w/ SOM)
The fifth & sixth authors are plastic surgeons. Neither has expertise in ID or COVID 5/
The 4th author @JoseGonzalesZa1 is the head of the ID fellowship at UMiami. He is an actual expert on this topic.
Based on his other work, I’m pretty sure he doesn’t think ivermectin is an effective therapy as this abstract concludes. See translation of one of his articles👇 6/
All of this makes me wonder - did the authors all even read/approve this abstract?
Did the peer reviewers think it was odd that plastic surgeons were doing research on ivermectin for COVID?
7/
I wonder if this abstract was the work of an eager group of students/residents who were inadequately supervised by more experienced researchers
That seems like the only way to explain such an obvious confounder being missed
This must have slipped past peer review at #IMED21 8/
Bottom line:
-this abstract of a retrospective review is fatally flawed due to the confounder of hospitalization (+more). There is no evidence that ivermectin reduces mortality
-it won’t stop fringe docs cashing in on selling ivermectin from promoting this “massive study” 9/9
• • •
Missing some Tweet in this thread? You can try to
force a refresh
Well designed RCT shows patients randomized to an exercise program had substantially improved survival after adjuvant chemotherapy for colon cancer.
- 5 yr disease-free survival 80.3% vs
73.9% (HR 0.72)
- 8 yr overall survival 90.3% vs 83.2% (HR 0.63)
This is groundbreaking! 1/
Some deets on the CHALLENGE trial
A 55 center trial done over 15 years (2009-2024) that randomized n=889 people with resected colon cancer after adjuvant chemotherapy to either:
- participate in a structured exercise program
- or to receive health-education materials alone
2/
The intervention was pretty comprehensive:
Personal activity consultant (PACs) - essentially trainers - got to know the participant 1:1, introduced them to the gym and came up with personalized activity goals
Regular every 2 week sessions helped participants reach the goals
Tragic news today about former president Biden's prostate cancer diagnosis. I wish him well.
As someone who follows presidential health reporting, I noticed something odd: unlike his predecessors, Biden's physician's never reported PSA.
How to interpret this absence? A🧵 1/
There are two possibilities:
1️⃣ Biden’s PSA was never checked
2️⃣ Biden’s PSA was checked but it wasn't reported
Strictly speaking, not checking PSA could be a medically correct option. Whether or not to test PSA is a complex question and is not the topic of this thread.
2/
Like many VIPs, presidents tend to have excessive testing that is not always strictly evidence-based.
For example, Bush 43 had an exercise treadmill test and a TB test for no apparent reason.
In honor of #MayThe4thBeWithYou let's consider the most difficult airways in the Star Wars universe:
1. Darth Vader
Species: human
Vader presents several challenges: Vent dependent at baseline, airway burns from Mustafar, limited neck mobility.
Discuss GOC before saving him
2. Fodesinbeed Annodue
Species: Trog
All airways require teamwork, but intubating Fodesinbeed Annodue's two heads really will require two operators.
Consider double simultaneous awake fiberoptic intubation
Be sure to consent both heads.
You will never find a more wretched hive of scum & challenging airways than Mos Eisley (except maybe at Jabba's)
3.Greedo
Species: Rodian
Micrognathia, posterior airway, no nasal intubation, green skin so no pulse ox
Approach: VL + bronchoscope. Intubate quickly (shoot first)
Every year, there is a predictable spike in fatal car accidents, medical errors, & heart attacks.
It’s estimated that there are thousands of excess deaths, a 1% increase in energy consumption, & billions of dollars in lost GDP.
The cause? Daylight savings transitions.
🧵
1/
Earth's axis of rotation and orbital axis are not precisely aligned. The 23.5 degree difference - 'axis tilt' - gives us our seasons and a noticeable difference in day length over the course of the year.
2/
For millennia this seasonal variation was an accepted fact of life.
In 1895, George Hudson, a New Zealand entomologist, was annoyed that less afternoon light meant less time for bug collecting.
He realized that clocks could be adjusted seasonally to align with daylight.
Unlike other Trump moves, this is arguably GOOD news for researchers!
If the NIH budget is unchanged (a big if), this allocates more money to researchers; if you go from an indirect of 75% to 15% it means you can fund 3 grants instead of 2.
Between 1947 and 1965, indirect rates ranged from 8% to 25% of total direct costs. In 1965, Congress removed most caps. Since then indirects have steadily risen.
2/
A lot of indirects go to thing like depreciation of facilities not paying salaries of support staff.
This accounting can be a little misleading.
If donors build a new $400m building, the institution can depreciate it & “lose” $20m/year over 20 years. Indirects pay this.
3/